News
Yale Biomedical Engineers Develop Nanoparticle Brain Cancer Treatment
In a recent study, Yale researchers developed a new way to more effectively treat brain cancer using nanoparticles.
Led by biomedical engineering professor Mark Saltzman and radiology professor Ranjit Bindra, the team first administered mice with medulloblastoma, a brain cancer that predominantly affects children. Then, they developed and used drug-carrying nanoparticles to deliver treatment over a sustained period of time. The study showed that mice who received this treatment lived significantly longer than mice who received traditional brain cancer treatment.
“This treatment is a way to directly target tumor cells in the central nervous system (CNS) with the potential to minimize toxic therapies, like radiation therapy to the CNS, as well as high doses of systemically administered chemotherapies,” Bindra told the News.
Source: Yale Daily News